Literature DB >> 8242635

Three discrete regions of deletion at 3p in head and neck cancers.

R Maestro1, D Gasparotto, T Vukosavljevic, L Barzan, S Sulfaro, M Boiocchi.   

Abstract

Alteration of the short arm of chromosome 3 is one of the most consistent cytogenetic abnormalities found in human head and neck cancers. These alterations, composed of translocations and deletions, have been associated with the presence of a tumor suppressor gene(s), but no clear evidence of the location of this presumptive gene(s) was available. We performed a molecular analysis of the 3p region using a polymerase chain reaction-based approach. Twenty-eight of the 38 cases analyzed (74%) showed the presence of single or multiple areas of allelic loss. Three commonly deleted regions, tentatively mapped to 3p24-ter, 3p21.3, and 3p14--cen, were identified. Our results suggest that at least three oncosuppressor genes mapping on 3p may be involved in head and neck cancer development and support a common oncogenic pathway with squamous cell lung cancer, for which a similar pattern of 3p deletion has been described recently.

Entities:  

Mesh:

Year:  1993        PMID: 8242635

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  Molecular analysis of oral lichen planus. A premalignant lesion?

Authors:  L Zhang; C Michelsen; X Cheng; T Zeng; R Priddy; M P Rosin
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  Inverted sinonasal papilloma : a molecular genetic appraisal of its putative status as a Precursor to squamous cell carcinoma.

Authors:  J Califano; W Koch; D Sidransky; W H Westra
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

3.  Allelic loss in human papillomavirus-positive and -negative vulvar squamous cell carcinomas.

Authors:  A P Pinto; M C Lin; G L Mutter; D Sun; L L Villa; C P Crum
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

4.  High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesis.

Authors:  Roberto Jose Diaz; Mustafa Guduk; Rocco Romagnuolo; Christian A Smith; Paul Northcott; David Shih; Fitim Berisha; Adrienne Flanagan; David G Munoz; Michael D Cusimano; M Necmettin Pamir; James T Rutka
Journal:  Neoplasia       Date:  2012-09       Impact factor: 5.715

5.  Chromosome 3p loss of heterozygosity and mutation analysis of the FHIT and beta-cat genes in squamous cell carcinoma of the head and neck.

Authors:  M V González; M F Pello; P Ablanedo; C Suárez; V Alvarez; E Coto
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

Review 6.  Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.

Authors:  V A Papadimitrakopoulou; D M Shin; W K Hong
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

7.  Genetic variations in regulator of G-protein signaling (RGS) confer risk of bladder cancer.

Authors:  Eugene K Lee; Yuanquing Ye; Ashish M Kamat; Xifeng Wu
Journal:  Cancer       Date:  2013-03-25       Impact factor: 6.860

8.  Single nucleotide polymorphism array analysis defines a specific genetic fingerprint for well-differentiated cutaneous SCCs.

Authors:  Karin J Purdie; Catherine A Harwood; Abha Gulati; Tracy Chaplin; Sally R Lambert; Rino Cerio; Gavin P Kelly; Jean-Baptiste Cazier; Bryan D Young; Irene M Leigh; Charlotte M Proby
Journal:  J Invest Dermatol       Date:  2009-01-08       Impact factor: 8.551

9.  Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder.

Authors:  M Li; Z F Zhang; V E Reuter; C Cordon-Cardo
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

10.  Loss of heterozygosity on chromosomes 3p,8p,9p and 17p in the progression of squamous cell carcinoma of the larynx.

Authors:  Woo Jeong Yoo; Seung Ho Cho; Youn Soo Lee; Gyeong Sin Park; Min Sik Kim; Byung Kee Kim; Won Sang Park; Jung Yong Lee; Chang Suk Kang
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.